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KIDNEY CANCER: ORIGINAL ARTICLE
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Abstract
Bilateral synchronous renal cell carcinoma (RCC) is uncommonly encountered. Debate exists among urologists in managing these cases in a 
single surgery versus staged surgeries. We aim to report our experience in managing encountered cases using single-stage surgeries. Retrospective 
collection of cases with pathologically confirmed RCC that had single-stage bilateral renal surgery over the past 2 years. Three cases were identi-
fied. Patients were managed using bilateral transverse lateral lumbotomy. All patients did not have intraoperative or postoperative complications. 
Kidney function stayed stable after surgery. Single-stage bilateral renal surgery is a safe procedure. Bilateral transverse lateral lumbotomy allows 
for a fast and safe surgery with minimal complications. There is a possible histological dis-concordance in bilateral synchronous RCC.
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The incidence of most cancers is on the rise. Canadian can-
cer statistics was expecting 7500 new kidney cancer diagnosis 
within 2020 with an age standardized incidence rate of 17.3 
in 100,000 population, with Ontario expected to have one-
third of the newly diagnosed cases (1). Bilateral renal cell 
carcinoma (RCC) occurs in less than 5% of kidney cancer, 
with the incidence of synchronous bilateral RCC being 1 out 
of 333 (0.3%) patients with RCC (2).
The aim of our work was to present our experience in 
managing synchronous bilateral RCC using single-stage 
bilateral transverse lateral lumbotomy incision.
Methods
Retrospective data analysis of patients having synchronous 
bilateral clinically suspected RCC, which was managed 
by single-stage surgery by a single urologist (AK), was the 
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method of choice. The urologist performing the surgery had 
15 years’ experience in performing renal cancer surgery. Data 
collection included information on patients’ age, sex and clin-
ical presentation, preoperative eGFR and images, patholog-
ical analysis, and postoperative eGFR. All cases included in 
the study were managed by open surgery. All had single-stage 
bilateral transverse lateral lumbotomy incision, an approach 
we published last year (3). During surgery, the patient is 
positioned with the side of surgery elevated to 45 degree. An 
upward smiling incision subcostal and running parallel to 
the costal margin is done. Direct adequate access to the kid-
ney could be done without the need for extensive diaphrag-
matic dissection. Full mobilization of the kidney and renal 
pedicle is done. The tumor is then identified and marked 
all around, few millimeters away from the tumor edge with 
cautery. We then clamp the pedicle and complete the surgery 
under warm ischemia. All patients had their first postoper-
ative computed tomography scan 12 months post-surgery. 
Our study included only patients that had single-stage bilat-
eral renal surgery. Institutional ethical approval as well as 
patients’ consent to be included in the study was obtained.
Results
We could identify three patients managed by single-stage 
bilateral renal surgery for clinically suspected RCC. All three 
patients were men with a median age of 76 years. They had 
their cancer diagnosed accidentally without symptoms sug-
gestive of renal tumor.
The first patient was 78 years old and was being followed 
by the vascular surgery team for a large abdominal aortic 
aneurysm (AAA), with bilateral enhancing renal masses 
diagnosed at the time of angiography. The right kidney had 
a single mass while the left kidney had multifocal tumors. 
The patient had single-stage left radical nephrectomy (RN) 
and right partial nephrectomy (PN). Pathology showed right 
clear-cell RCC (ccRCC) and left papillary RCC (pRCC) with 
negative margins. His eGFR was stable at 14 months after 
surgery and a new scan 1-year post surgery confirmed no 
cancer recurrence. Figure 1 shows the bilateral renal tumor, 
AAA, and a postoperative scan.
The second patient was 76 years old with a history of left 
open PN for ccRCC and a negative margin done 5 years ago. 
CT scan performed as part of postoperative surveillance 
diagnosed a suspected suspicious renal tumor with the left 
side being at the same area as that of the previous PN. Bilat-
eral PN could be successfully done in a single stage. Pathol-
ogy confirmed bilateral ccRCC, with negative margins. 
eGFR is stable at 12 months post-surgery. Figure 2 shows 
the bilateral renal tumors.
The third patient was 63 years old. He initially had a 
right enhanced renal mass (1.5 cm), accidentally diagnosed 
Figure 1: First patient: preoperative bilateral renal tumor, large AAA, and 14 months’ postoperative image showing no recurrence.
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open surgery was performed, but the exact approach was not 
provided. On the other hand, Wang et al. (6) studied four 
patients managed by single-stage bilateral retroperitoneo-
scopic surgeries for renal tumors over a period of 6 years and 
found that four patients developed acute renal insufficiency 
and recommended staged surgeries rather than single stage 
for patients with bilateral renal tumors.
All our patients were managed through single-stage bilat-
eral open retroperitoneal surgery through the transverse lat-
eral lumbotomy incision. Our approach allowed easy direct 
access to the kidney and the renal pedicle, without the risk 
of pleural injury and by avoiding unnecessary exposure of 
the intraperitoneal organs. We usually start with the side 
having the larger or more difficult tumor, dissect the whole 
kidney and the pedicle, mark the area of resection around 
the tumor with cautery, and then apply warm ischemia. After 
removing the tumor and repairing the collecting system, we 
take few deep transverse mattress sutures to stop bleeding, 
then unclamp the pedicle and continue with renorrhaphy. We 
keep blood loss and WIT to the minimal, so as to avoid the 
risk of acute kidney injury. As our approach is subcostal, 
pain is well managed, better than the conventional supra-
costal approach, and the power of breathing is not affected 
in bilateral surgery as it avoids the extensive diaphragmatic 
dissection associated with the conventional open retroperi-
toneal approach. We could not identify studies that looked 
specifically at patients with Von Hippel–Lindau syndrome, 
but as renal tumors associated with this syndrome tend to 
grow faster, single-stage bilateral surgery should be consid-
ered whenever feasible.
Renal biopsy is generally not recommended for enhanced 
renal mass before surgery, unless some other pathology is 
following an ultrasound for a vague abdominal pain. He 
elected for surveillance, and CT done after 1 year showed 
a stable right renal tumor and a new left renal tumor. Sin-
gle-stage bilateral PN was done. Pathology showed bilateral 
ccRCC with negative margins. eGFR was stable at 12 months 
post-surgery. Figure 3 shows the bilateral renal tumors.
All PNs for these patients were stage T1a and were man-
aged through single-stage bilateral transverse lateral lumbot-
omy. Our surgical approach has been presented in former 
publications (3, 4).
Warm ischemia was used for all cases undergoing PN and 
median warm ischemic time (WIT) was 10 min (4–16 min). 
The median surgical time was 120 min (90, 180, and 120 min, 
respectively). No blood transfusion was required during 
surgery or the postoperative period. The median hospital 
stay was 3 days (5, 3, and 2 days, respectively). We did not 
have any grade 3 or higher Clavien grade complications in 
the three patients. Table 1 summarizes patients’ clinical and 
pathological outcomes.
Discussion
Bilateral renal malignancy is infrequently encountered and 
the choice of single stage versus staged bilateral renal surgery 
is debatable and usually left to the preference of the operating 
surgeon. Single-stage bilateral renal surgery carries the bene-
fit of a single anesthetic exposure in these patients with pos-
sible associated morbidities, but it is usually feared because 
of the anticipated higher risk of complications. Mason 
et al. (5) conducted a retrospective study on 76 patients who 
underwent single-stage bilateral PN over a period of 39 years 
and confirmed the safety of synchronous bilateral renal sur-
gery, albeit with a complication rate of 20%. In this study, 
Figure 2: Second patient: bilateral renal tumor.
Figure 3: Third patient: bilateral renal tumor.
Kotb A et al.
 Journal of Kidney Cancer and VHL 2021; 8(1): 7–11 10
suspected or a minimally invasive intervention like radiof-
requency ablation is planned. As our three patients elected 
for surgery and CT clearly showed enhanced heterogenous 
masses, surgery was directly planned.
Klatte et al. (7) conducted an international multicentric 
study from 12 urological centers studying 118 patients who 
presented with synchronous bilateral RCC. Half of the 
patients were managed through a single-stage bilateral sur-
gery. The authors confirmed equal oncological and func-
tional outcomes. They added that synchronous renal RCC 
tends to have a higher frequency of papillary histology than 
unilateral cases. A large review of the SEER database for 
patients with bilateral solid renal tumors found a malignant 
concordance rate of 99% and a histological concordance rate 
Table 1: Summary of patients’ clinical and pathological outcomes.
First patient Second patient Third patient
Sex Male Male Male 
Age 78 76 63
Previous kidney surgery No Yes No 








Bilateral PN Bilateral PN
Total surgical time (minutes) 90 180 120
Total WIT (minutes) 4 16 10
Pathology ccRCC and pRCC ccRCC ccRCC
Margins Negative Negative Negative 
Tumor size (cm) Right 1.5 2 1.5
Left Multiple (2, 3, and 3) 2.5 2
Stage Right T1a T1a T1a
Left T2 T1a T1a
Fuhrman grade Right 3 3 3
Left N/A 4 2
Hospital stay 5 3 2
Preoperative eGFR 55 58 70
Postoperative eGFR 50 52 63
Clavien 3 or higher complication None None None 
Cancer recurrence in 1 year None None None 
of 93% (8). In our series, one out of three patients had his-
tological dis-concordance with clear-cell histology identified 
in one kidney and papillary histology in the other kidney. 
Arnoux et al. (9) found that ccRCC is associated with pRCC 
in 3% of cases.
Reddy et al. (10) reported grade 3 or higher complica-
tions in nearly 15% of their cases managed by PN, mostly 
manifested in the form of urine leak or bleeding requiring 
exploration or embolization. We did not encounter these 
complications in any of the three patients.
The main limitation of our report is the less number of 
patients; however, this together with the available few other 
reports may confirm the safety of single-stage bilateral renal 
cancer surgery. Although Canadian urological association 
Synchronous RCC
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guidelines recommend first postoperative CT to be done at 
24 months (11), we elected to do it at 12 months considering 
the possible higher risk of recurrence attributed to synchro-
nous bilateral cancer. CT failed to identify any recurrent dis-
ease in all patients.
Conclusion
Single-stage bilateral renal surgery is a safe procedure in 
experienced hands. Bilateral transverse lateral lumbotomy 
allows for a fast and safe surgery with minimal complica-
tions. There is a possible histological dis-concordance in 
bilateral synchronous RCC.
Conflict of interest
Nothing to declare from all authors.
References
1. Brenner DR, Weir HK, Demers AA, Ellison LF, Louzado C, 
Shaw A, et al. Projected estimates of cancer in Canada in 2020. 
Can Med Assoc J. 2020 Mar 2;192(9):E199–205. https://doi.
org/10.1503/cmaj.191292
2. Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, 
Adami HO. Risk of bilateral renal cell cancer. Ncol. 2009 Aug 
10;27(23):3737–41. https://doi.org/10.1200/JCO.2008.20.6524
3. Ismail A, Oquendo F, Allard-Ihala E, Elmansy H, Shahrour W, 
Prowse O, et al. Transverse lumbotomy for open partial/radical 
nephrectomy: How I do it. Urol Int. 2020;104(1–2):131–134. 
https://doi.org/10.1159/000504787
4. Kotb A, Ismail A, Elmansy H, Prowse O, Shahrour W. 
Spontaneous retroperitoneal hemorrhage in a patient with 
acquired cystic kidney disease. J Kidney Cancer VHL. 2020 Apr 
16;7(1):1–4. https://doi.org/10.15586/jkcvhl.2020.123
5. Mason RJ, Atwell T, Lohse C, Bhindi B, Schmit G, Schmitz J, 
et  al. Synchronous nephron-sparing approaches for bilateral 
renal masses: peri-operative and renal functional outcomes. BJU 
Int. 2018 Aug;122(2):243–8. https://doi.org/10.1111/bju.14221
6. Wang B, Gong H, Zhang X, Li H, Ma X, Song E, et  al. 
Bilateral synchronous sporadic renal cell carcinoma: 
Retroperitoneoscopic strategies and intermediate outcomes of 
60 patients. PLoS One. 2016 May 2;11(5):e0154578. https://doi.
org/10.1371/journal.pone.0154578
7. Klatte T, Wunderlich H, Patard JJ, Kleid MD, Lam JS, 
Junker  K, et al. Clinicopathological features and prognosis of 
synchronous bilateral renal cell carcinoma: An international 
multicentre experience. BJU Int. 2007 Jul;100(1):21–5. https://
doi.org/10.1111/j.1464-410X.2007.06877.x
8. Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, 
Uzzo  RG. Pathologic concordance of sporadic synchronous 
bilateral renal masses. Urology. 2008 Jul;72(1):138–42. https://
doi.org/10.1016/j.urology.2008.01.043
9. Arnoux V, Fiard G, Descotes JL, Rambeaud JI, Long JA. 
Bilateral renal masses: Pathologic concordance and impact 
of temporal presentation. Minerva Urol Nefrol. 2012 
Dec;64(4):287–93.
10. Reddy UD, Pillai R, Parker RA, Weston J, Burgess NA, 
Ho ET, et al. Prediction of complications after partial nephrec-
tomy by RENAL nephrometry score. Ann R Coll Surg 
Engl. 2014 Sep;96(6):475–9. https://doi.org/10.1308/0035884
14X13946184903522
11. Kassouf W, Monteiro LL, Drachenberg DE, Fairey AS, 
Finelli  A, Kapoor A, et al. Canadian Urological Association 
guideline for followup of patients after treatment of non-met-
astatic renal cell carcinoma. Can Urol Assoc J. 2018 
Aug;12(8):231–8. https://doi.org/10.5489/cuaj.5462
